High prevalence of bla OXA-23 in Acinetobacter spp. and detection of bla NDM-1 in A. soli in Cuba: report from National Surveillance Program (2010-2012)
- PMID: 26236494
- PMCID: PMC4511621
- DOI: 10.1016/j.nmni.2015.06.002
High prevalence of bla OXA-23 in Acinetobacter spp. and detection of bla NDM-1 in A. soli in Cuba: report from National Surveillance Program (2010-2012)
Abstract
As a first national surveillance of Acinetobacter in Cuba, a total of 500 Acinetobacter spp. isolates recovered from 30 hospitals between 2010 and 2012 were studied. Acinetobacter baumannii-calcoaceticus complex accounted for 96.4% of all the Acinetobacter isolates, while other species were detected at low frequency (A. junii 1.6%, A. lwoffii 1%, A. haemolyticus 0.8%, A. soli 0.2%). Resistance rates of isolates were 34-61% to third-generation cephalosporins, 49-50% to β-lactams/inhibitor combinations, 42-47% to aminoglycosides, 42-44% to carbapenems and 55% to ciprofloxacin. However, resistance rates to colistin, doxycycline, tetracycline and rifampin were less than 5%. Among carbapenem-resistant isolates, 75% harboured different bla OXA genes (OXA-23, 73%; OXA-24, 18%; OXA-58, 3%). The bla NDM-1 gene was identified in an A. soli strain, of which the species was confirmed by sequence analysis of 16S rRNA gene, rpoB, rpoB-rpoC and rpoL-rpoB intergenic spacer regions and gyrB. The sequences of bla NDM-1 and its surrounding genes were identical to those reported for plasmids of A. baumannii and A. lwoffi strains. This is the first report of bla NDM-1 in A. soli, together with a high prevalence of OXA-23 carbapenemase for carbapenem resistance in Acinetobacter spp. in Cuba.
Keywords: Acinetobacter; Cuba; NDM-1; OXA-23; carbapenem resistance.
Figures
Similar articles
-
Clonal diversity of Acinetobacter clinical isolates producing NDM-type carbapenemase in Cuba, 2013-19.IJID Reg. 2022 Aug 29;5:93-96. doi: 10.1016/j.ijregi.2022.08.008. eCollection 2022 Dec. IJID Reg. 2022. PMID: 36247096 Free PMC article.
-
Carbapenem Resistance in Acinetobacter baumannii and Other Acinetobacter spp. Causing Neonatal Sepsis: Focus on NDM-1 and Its Linkage to ISAba125.Front Microbiol. 2016 Aug 8;7:1126. doi: 10.3389/fmicb.2016.01126. eCollection 2016. Front Microbiol. 2016. PMID: 27551277 Free PMC article.
-
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.Antimicrob Agents Chemother. 2007 Nov;51(11):4022-8. doi: 10.1128/AAC.01259-06. Epub 2007 Sep 10. Antimicrob Agents Chemother. 2007. PMID: 17846127 Free PMC article.
-
Acinetobacter spp. Infections in Malaysia: A Review of Antimicrobial Resistance Trends, Mechanisms and Epidemiology.Front Microbiol. 2017 Dec 12;8:2479. doi: 10.3389/fmicb.2017.02479. eCollection 2017. Front Microbiol. 2017. PMID: 29312188 Free PMC article. Review.
-
Accurate identification of clinically important Acinetobacter spp.: an update.Future Sci OA. 2019 Jun 27;5(6):FSO395. doi: 10.2144/fsoa-2018-0127. Future Sci OA. 2019. PMID: 31285840 Free PMC article. Review.
Cited by
-
Clonal diversity of Acinetobacter clinical isolates producing NDM-type carbapenemase in Cuba, 2013-19.IJID Reg. 2022 Aug 29;5:93-96. doi: 10.1016/j.ijregi.2022.08.008. eCollection 2022 Dec. IJID Reg. 2022. PMID: 36247096 Free PMC article.
-
Withdrawal of Colistin Reduces Incidence of mcr-1-Harboring IncX4-Type Plasmids but Has Limited Effects on Unrelated Antibiotic Resistance.Pathogens. 2021 Aug 12;10(8):1019. doi: 10.3390/pathogens10081019. Pathogens. 2021. PMID: 34451483 Free PMC article.
-
Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It.Vaccines (Basel). 2021 Jun 1;9(6):570. doi: 10.3390/vaccines9060570. Vaccines (Basel). 2021. PMID: 34205838 Free PMC article. Review.
-
Analysis of beta-lactamases, blaNDM-1phylogeny & plasmid replicons in multidrug-resistant Klebsiella spp. from a tertiary care centre in south India.Indian J Med Res. 2017 Jul;146(Supplement):S38-S45. doi: 10.4103/ijmr.IJMR_31_16. Indian J Med Res. 2017. PMID: 29205194 Free PMC article.
-
Carbapenemases producing gram-negative bacteria surveillance in Latin America and the caribbean: a retrospective observational study from 2015 to 2020.Lancet Reg Health Am. 2025 Jul 15;49:101185. doi: 10.1016/j.lana.2025.101185. eCollection 2025 Sep. Lancet Reg Health Am. 2025. PMID: 40697529 Free PMC article.
References
-
- Durante-Mangoni E., Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 2011;6:407–422. - PubMed
-
- Espinal P., Roca I., Vila J. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter. Future Microbiol. 2011;6:495–511. - PubMed
-
- Park Y.K., Jung S.I., Park K.H., Kim S.H., Ko K.S. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Int J Antimicrob Agents. 2012;39:81–85. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous